Public company research profile

This public-disclosure research profile is not investment advice. It summarizes historical public filings, source links, confidence context, and hypothetical outcomes so readers can verify the evidence themselves.

Open in CopyWindow

Company research history

Insmed Incorporated - Common Stock (INSM)

Source-transparent disclosure history for this company, built from public CopyWindow signals and previous hypothetical outcomes.

8 disclosures
2 insiders
0 cluster signals
0.0% avg. 30d outcome

Company facts

Ticker / ISIN
INSM / Not available
Exchange
Not available
Country
US
Sector
Not available

Disclosure history

Gilbert Cisneros, Representative

sell disclosed on 18 Nov 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Gilbert Cisneros, Representative

sell disclosed on 12 Sept 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Gilbert Cisneros, Representative

sell disclosed on 14 Aug 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Josh Gottheimer, Representative

buy disclosed on 16 Jul 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Josh Gottheimer, Representative

sell disclosed on 14 May 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Josh Gottheimer, Representative

sell disclosed on 9 Jul 2024 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Josh Gottheimer, Representative

sell disclosed on 8 Jun 2024 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Josh Gottheimer, Representative

buy disclosed on 13 Jan 2023 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%